Jonathan Kuten

605 total citations
23 papers, 419 citations indexed

About

Jonathan Kuten is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Jonathan Kuten has authored 23 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Jonathan Kuten's work include Prostate Cancer Treatment and Research (12 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Jonathan Kuten is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Jonathan Kuten collaborates with scholars based in Israel, United States and Sweden. Jonathan Kuten's co-authors include Einat Even‐Sapir, Ofer Yossepowitch, Eyal Mishani, Ofer Shamni, Nicola J. Mabjeesh, Gilad Gitstein, Charles Levine, Dov Hershkovitz, Ziv Savin and Guy Lahat and has published in prestigious journals such as American Journal of Roentgenology, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Jonathan Kuten

21 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Kuten Israel 12 252 194 149 91 78 23 419
Salvatore Cozzi Italy 14 216 0.9× 84 0.4× 112 0.8× 65 0.7× 68 0.9× 46 422
Selina Kiefer Germany 11 302 1.2× 201 1.0× 93 0.6× 56 0.6× 30 0.4× 16 448
Gianpaolo di Santo Italy 10 358 1.4× 263 1.4× 92 0.6× 76 0.8× 17 0.2× 24 499
Sofia C. Vaz Portugal 12 176 0.7× 245 1.3× 95 0.6× 68 0.7× 61 0.8× 36 429
Yasuhiro Sasakawa Japan 11 164 0.7× 315 1.6× 132 0.9× 52 0.6× 104 1.3× 19 525
Anna Kuisma Finland 8 288 1.1× 338 1.7× 156 1.0× 42 0.5× 32 0.4× 11 489
Reyhaneh Manafi‐Farid Iran 12 175 0.7× 208 1.1× 118 0.8× 37 0.4× 36 0.5× 25 339
Marit Ahrens Germany 9 171 0.7× 88 0.5× 226 1.5× 108 1.2× 108 1.4× 22 378
Eija Sutinen Finland 9 228 0.9× 323 1.7× 53 0.4× 80 0.9× 56 0.7× 11 560
Adrien Holzgreve Germany 12 164 0.7× 278 1.4× 125 0.8× 42 0.5× 82 1.1× 76 518

Countries citing papers authored by Jonathan Kuten

Since Specialization
Citations

This map shows the geographic impact of Jonathan Kuten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Kuten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Kuten more than expected).

Fields of papers citing papers by Jonathan Kuten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Kuten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Kuten. The network helps show where Jonathan Kuten may publish in the future.

Co-authorship network of co-authors of Jonathan Kuten

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Kuten. A scholar is included among the top collaborators of Jonathan Kuten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Kuten. Jonathan Kuten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grkovski, Milan, Simone Krebs, Joseph A. O’Donoghue, et al.. (2025). Lesion Absorbed Dose–Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 66(10). 1622–1630. 2 indexed citations
2.
Kuten, Jonathan, Ziv Savin, Roy Mano, et al.. (2024). A novel tool to predict lymph node metastasis in patients with prostate cancer based on clinical and 68Ga-PSMA PET/CT parameters. Canadian Urological Association Journal. 19(4). E257–E263. 1 indexed citations
3.
4.
Kuten, Jonathan, Jeffrey Campbell, Yuval Bar‐Yosef, et al.. (2022). 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer. Canadian Urological Association Journal. 16(7). E381–E385. 11 indexed citations
5.
Kuten, Jonathan, Charles Levine, David Sarid, et al.. (2021). Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement. European Journal of Nuclear Medicine and Molecular Imaging. 49(6). 2077–2085. 13 indexed citations
6.
7.
8.
Kuten, Jonathan, Gilad Gitstein, Daniel Keizman, et al.. (2021). Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection. Prostate Cancer and Prostatic Diseases. 24(3). 910–916. 12 indexed citations
9.
Kuten, Jonathan, Charles Levine, Ofer Shamni, et al.. (2021). Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 49(2). 743–750. 87 indexed citations
10.
Kuten, Jonathan, et al.. (2021). [THE ROLE OF PSMA PET/CT IN IMAGING PROSTATE CANCER].. PubMed. 160(7). 455–461. 1 indexed citations
11.
Freedman, Nanette, et al.. (2020). Personalized radiation dosimetry for PRRT—how many scans are really required?. EJNMMI Physics. 7(1). 26–26. 22 indexed citations
12.
Kuten, Jonathan, et al.. (2019). Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy. Surgical Oncology. 30. 1–5. 2 indexed citations
13.
Kuten, Jonathan, et al.. (2019). 68Ga-PSMA PET/CT: Does it predict adverse pathology findings at radical prostatectomy?. Urologic Oncology Seminars and Original Investigations. 37(9). 574.e19–574.e24. 12 indexed citations
14.
Kuten, Jonathan, Ziv Savin, Ofer Shamni, et al.. (2019). Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard. Journal of Nuclear Medicine. 61(4). 527–532. 156 indexed citations
15.
Giladi, Nir, et al.. (2019). The Added Value of 18F-FDOPA PET/CT in the Work-Up of Patients with Movement Disorders. Neurographics. 9(5). 344–348. 4 indexed citations
16.
Kuten, Jonathan, et al.. (2019). Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer.. PubMed. 21(2). 100–104. 13 indexed citations
17.
Kuten, Jonathan, David Sarid, Ofer Yossepowitch, Nicola J. Mabjeesh, & Einat Even‐Sapir. (2019). [68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?. EJNMMI Research. 9(1). 84–84. 21 indexed citations
18.
Zadik, Yehuda, et al.. (2018). Long-term scopolamine treatment and dental caries. Clinical Oral Investigations. 23(5). 2339–2344. 5 indexed citations
19.
Kuten, Jonathan, Orit Kaidar‐Person, Eugene Vlodavsky, et al.. (2012). Anaplastic Ganglioglioma in the Spinal Cord: Case Report and Literature Review. Pediatric Neurosurgery. 48(4). 245–248. 9 indexed citations
20.
Kaidar‐Person, Orit, et al.. (2012). Brain Metastasis of Nasopharyngeal Carcinoma: A Case Report and Literature Review. Case Reports in Medicine. 2012. 1–4. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Cozzi Breakdown of academic impact, for papers by Selina Kiefer Breakdown of academic impact, for papers by Gianpaolo di Santo Breakdown of academic impact, for papers by Sofia C. Vaz Breakdown of academic impact, for papers by Yasuhiro Sasakawa Breakdown of academic impact, for papers by Anna Kuisma Breakdown of academic impact, for papers by Reyhaneh Manafi‐Farid Breakdown of academic impact, for papers by Marit Ahrens Breakdown of academic impact, for papers by Eija Sutinen Breakdown of academic impact, for papers by Adrien Holzgreve
Rankless by CCL
2026